VALERIE MULLINS: Open Payments
NPI 1760775365 · GREENEVILLE, TN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,307 in 86 payments from 19 companies in 2025. Trend: 2023 $2,127 · 2024 $1,468 · 2025 $1,307
Food & beverage: $1,307
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 33 | $291 |
| Novo Nordisk Inc | 11 | $176 |
| Otsuka America Pharmaceutical, Inc. | 7 | $167 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 6 | $135 |
| GlaxoSmithKline, LLC. | 3 | $70 |
| PFIZER INC. | 4 | $68 |
| Exact Sciences Corporation | 4 | $63 |
| Lundbeck LLC | 3 | $55 |
| Axsome Therapeutics, Inc. | 3 | $54 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $43 |
Products named: REXULTI, CAPLYTA, VRAYLAR, UBRELVY, Ozempic, QULIPTA, TRELEGY ELLIPTA, The Cologuard Plus Collection Kit.
Industry payments across TN — which companies pay providers there.
